Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients
…, JJ Dennis, RJ Regimbal, PR Bauer, JE Blair… - Mayo Clinic …, 2020 - Elsevier
Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
[HTML][HTML] Early safety indicators of COVID-19 convalescent plasma in 5000 patients
…, RJ Regimbal, PR Bauer, JE Blair… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
[HTML][HTML] Early outpatient treatment for Covid-19 with convalescent plasma
Background Polyclonal convalescent plasma may be obtained from donors who have
recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing …
recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing …
Coccidioidomycosis
JN Galgiani, NM Ampel, JE Blair… - Clinical Infectious …, 2005 - academic.oup.com
Management of coccidioidomycosis first involves recognizing that a coccidioidal infection
exists, defining the extent of infection, and identifying host factors that predispose to disease …
exists, defining the extent of infection, and identifying host factors that predispose to disease …
[HTML][HTML] Convalescent plasma antibody levels and the risk of death from Covid-19
…, RJ Regimbal, PR Bauer, JE Blair… - … England Journal of …, 2021 - Mass Medical Soc
Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …
under the presumption that such plasma contains potentially therapeutic …
2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis
JN Galgiani, NM Ampel, JE Blair… - Clinical Infectious …, 2016 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …
patients. They are not intended to supplant physician judgment with respect to particular …
Coccidioidomycosis in solid organ transplantation
JE Blair, JL Logan - Clinical infectious diseases, 2001 - academic.oup.com
Coccidioidomycosis is an endemic fungal infection of the southwestern United States.
Normally a self-limited infection in healthy hosts, coccidioidomycosis can become a serious …
Normally a self-limited infection in healthy hosts, coccidioidomycosis can become a serious …
The cephalosporins
WF Marshall, JE Blair - Mayo Clinic Proceedings, 1999 - Elsevier
The cephalosporins are a large group of related β-lactam antimicrobial agents. Favorable
attributes of the cephalosporins include low rates of toxicity, relatively broad spectrum of activity…
attributes of the cephalosporins include low rates of toxicity, relatively broad spectrum of activity…
[HTML][HTML] Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts
JE Blair, B Coakley, AC Santelli, JG Hentz… - Mycopathologia, 2006 - Springer
Serologic studies are an important diagnostic tool in the clinical evaluation and follow-up of
persons with coccidioidomycosis. Numerous types of serologic tests are available, including …
persons with coccidioidomycosis. Numerous types of serologic tests are available, including …
[PDF][PDF] Bacterial, mycobacterial, and protozoal infections after liver transplantation—part I
JE Blair, S Kusne - Liver transplantation, 2005 - Wiley Online Library
Infection is one of the leading causes of morbidity and mortality in liver transplant recipients.
More than two-thirds of liver transplant recipients have infection in the first year after …
More than two-thirds of liver transplant recipients have infection in the first year after …